Found: 71
Select item for more details and to access through your institution.
Deterioration of storage phosphor screens with use.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2002, v. 45, n. 4, p. 339, doi. 10.1002/jlcr.551
- By:
- Publication type:
- Article
A Longitudinal Study of Behavioral Deficits in an AβPP Transgenic Mouse Model of Alzheimer's Disease.
- Published in:
- Journal of Alzheimer's Disease, 2011, v. 25, n. 2, p. 231, doi. 10.3233/JAD-2011-101866
- By:
- Publication type:
- Article
A longitudinal study of behavioral deficits in an AβPP transgenic mouse model of Alzheimer's disease.
- Published in:
- 2011
- By:
- Publication type:
- journal article
L-Type Calcium Channel Ca<sub>V</sub> 1.2 in Transgenic Mice Overexpressing Human AβPP751 with the London (V717I) and Swedish (K670M/N671L) Mutations.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 20, n. 4, p. 1167, doi. 10.3233/JAD-2010-091117
- By:
- Publication type:
- Article
Chromogranin B and Secretogranin II in transgenic mice overexpressing human APP751 with the London (V717I) and Swedish (K670M/N671L) mutations and in Alzheimer patients.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Chromogranin B and Secretogranin II in Transgenic Mice Overexpressing Human APP751 with the London (V717I) and Swedish (K670M/N671L) Mutations and in Alzheimer Patients.
- Published in:
- Journal of Alzheimer's Disease, 2008, v. 13, n. 2, p. 123, doi. 10.3233/JAD-2008-13202
- By:
- Publication type:
- Article
NEUROPROTECTION IN TWO DIFFERENT TISSUE CULTURE MODELS OF BRAIN ISCHEMIA: INFLUENCE OF CEREBROLYSIN.
- Published in:
- 2007
- By:
- Publication type:
- Abstract
Age‐dependent effects of the p75 neurotrophin receptor modulator LM11A‐31 on Alzheimer's disease biomarkers in a 26‐week safety and exploratory endpoint trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.069079
- By:
- Publication type:
- Article
Development of an orally bioavailable stress kinase inhibitor with brain exposure that targets the neuroinflammation‐synaptic dysfunction pathophysiology axis: Human/Human trials: Other.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046530
- By:
- Publication type:
- Article
Clinical phase I data of the first orally available anti‐aβ‐prionic drug PRI‐002 that reverses behavioral and cognitive deficits, and decelerates neurodegeneration in AD animal models: Human/Human trials: Other.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.038821
- By:
- Publication type:
- Article
Diffusion Kurtosis Imaging Detects Microstructural Alterations in Brain of α-Synuclein Overexpressing Transgenic Mouse Model of Parkinson's Disease: A Pilot Study.
- Published in:
- Neurotoxicity Research, 2015, v. 28, n. 4, p. 281, doi. 10.1007/s12640-015-9537-9
- By:
- Publication type:
- Article
Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology.
- Published in:
- Nature Medicine, 2008, v. 14, n. 10, p. 1106, doi. 10.1038/nm.1872
- By:
- Publication type:
- Article
EFFECTS OF TREATMENT WITH DOXYCYCLINE ON BEHAVIOR, NEUROINFLAMMATION AND BRAIN PATHOLOGY IN THE RTG-4510 MOUSE MODEL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P843, doi. 10.1016/j.jalz.2016.06.1726
- By:
- Publication type:
- Article
DIFFERENCES BETWEEN TG2576- AND APP/PS1 MICE IN HIGH-THROUGHPUT BEHAVIORAL SCREENING CORRELATES WITH DIFFERENCES IN BRAIN PATHOLOGY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P1029, doi. 10.1016/j.jalz.2016.06.2128
- By:
- Publication type:
- Article
Scopolamine disrupts allocentric spatial navigation in humans: The study in a real-space analogue of the morris water maze.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P825, doi. 10.1016/j.jalz.2015.06.1829
- By:
- Publication type:
- Article
Spatial navigation testing in the assessment of patients with mild Alzheimer's disease treated by cholinesterase inhibitors
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Novel mutated tau441 overexpressing in vitro and in vivo models are characterized by hyperphosphorylated tau
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Characterization of APPsi transgenic rats for cognitive deficits and brain pathology
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Association between neuropathology and spatial learning in transgenic hAPPSL × hTAU crossbred mice
- Published in:
- 2011
- By:
- Publication type:
- Abstract
New mouse model to develop and test drugs against the human Glutaminyl Cyclase (hQC) for Alzheimer's disease research
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Transgenic mouse models with increased pyroglutamate-abeta formation show early phenotypic changes
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Sodium selenate specifically boosts PP2A phosphatase, dephosphorylates tau and reverses memory deficits and prevents neurofibrillary tangle formation in Alzheimer's disease models
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Changes in AB42 levels are associated with the functional outcome in Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Characterization of an Alzheimer mouse model over-expressing mutated human TAU
- Published in:
- 2010
- By:
- Publication type:
- Abstract
A New Biogenic hAPP x hTau Mouse Model Shows Progressive Brain Pathology and Behavioral Disturbance
- Published in:
- 2010
- By:
- Publication type:
- Abstract
hAPP-SL x hTau crossbreds: A mouse model combining two major Alzheimer hallmarks
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Effects of secretase inhibitors on APP processing in primary cultures of embryonic chicken cortical neurons
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Inhibition of glutaminyl cyclase reduces amyloid pathology in transgenic animals
- Published in:
- 2009
- By:
- Publication type:
- Abstract
P2-333: The gamma-secretase modulator CHF5074 acutely reduces brain Aβ42 in the guinea pig model of human β-amyloid production
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P2-301: Reduced brain β-amyloid burden, associated microglia inflammation and spatial memory deficit in hAPP transgenic mice treated for six months with CHF5074, a novel gamma-secretase modulator
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P1-138: Effects of different secretase inhibitors on APP processing in primary cultures of chicken cortical neurons
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P1-093: Gender-specific development of brain pathology and functional deficits in A hAPP<sub>SL</sub> mouse model of Alzheimer's disease (TASD41)
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P1-085: Progression of brain pathology and behavioural disturbance in a mouse model (TMHT) overexpressing mutated human TAU
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P4-424: β-synuclein derived small peptides for treatment of Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-118: Establishment of brain slice cultures from alpha synuclein transgenic mice for drug screening
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-119: Establishment of a p75NTR transgenic mouse model
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-105: A new screening model for neurodegenerative diseases
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-094: New transgenic TAU mouse model with cognitive disturbances
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P4-424: β-synuclein derived small peptides for treatment of Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-119: Establishment of a p75NTR transgenic mouse model
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-118: Establishment of brain slice cultures from alpha synuclein transgenic mice for drug screening
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-105: A new screening model for neurodegenerative diseases
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-094: New transgenic TAU mouse model with cognitive disturbances
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Stable Mutated tau441 Transfected SH-SY5Y Cells as Screening Tool for Alzheimer's Disease Drug Candidates.
- Published in:
- Journal of Molecular Neuroscience, 2012, v. 47, n. 1, p. 192, doi. 10.1007/s12031-012-9716-6
- By:
- Publication type:
- Article
The γ-Secretase Modulator CHF5074 Reduces the Accumulation of Native Hyperphosphorylated Tau in a Transgenic Mouse Model of Alzheimer's Disease.
- Published in:
- Journal of Molecular Neuroscience, 2011, v. 45, n. 1, p. 22, doi. 10.1007/s12031-010-9482-2
- By:
- Publication type:
- Article
Comparison of Pharmacological Modulation of APP Metabolism in Primary Chicken Telencephalic Neurons and in a Human Neuroglioma Cell Line.
- Published in:
- Journal of Molecular Neuroscience, 2011, v. 43, n. 3, p. 257, doi. 10.1007/s12031-010-9416-z
- By:
- Publication type:
- Article
Establishment of Stably Transfected Rat Neuronal Cell Lines Expressing α-Synuclein GFP Fusion Proteins.
- Published in:
- Journal of Molecular Neuroscience, 2010, v. 41, n. 1, p. 80, doi. 10.1007/s12031-009-9289-1
- By:
- Publication type:
- Article
β-synuclein-derived peptides with neuroprotective activity.
- Published in:
- Journal of Molecular Neuroscience, 2004, v. 24, n. 1, p. 155, doi. 10.1385/JMN:24:1:155
- By:
- Publication type:
- Article
Development of a new treatment for alzheimer’s disease and parkinson’s disease using anti-aggregatory β-synuclein-derived peptides.
- Published in:
- Journal of Molecular Neuroscience, 2002, v. 19, n. 1/2, p. 63, doi. 10.1007/s12031-002-0012-8
- By:
- Publication type:
- Article
Tracking of Magnetite Labeled Nanoparticles in the Rat Brain Using MRI.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0092068
- By:
- Publication type:
- Article